• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

执业护士对骨质疏松症的筛查、评估及治疗:临床实践关键问答——加拿大视角

Screening, assessment, and treatment of osteoporosis for the nurse practitioner: key questions and answers for clinical practice--a Canadian perspective.

作者信息

Rice Peggy, Mehan Upender, Hamilton Celeste, Kim Sandra

机构信息

Lakeridge Health Whitby PASS Program, Whitby, Ontario, Canada.

出版信息

J Am Assoc Nurse Pract. 2014 Jul;26(7):378-85. doi: 10.1002/2327-6924.12134. Epub 2014 Jun 9.

DOI:10.1002/2327-6924.12134
PMID:24911524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4140610/
Abstract

PURPOSE

Using a case-based approach, we review key clinical questions relevant to nurse practitioners (NPs) regarding the screening, assessment, and treatment of patients at risk for osteoporosis and fractures in a Canadian general practice setting.

DATA SOURCES

A case presentation with relevant questions and answers to guide management of a patient.

CONCLUSIONS

Osteoporosis is a common condition in both the aging male and female populations. Screening, diagnosis, and treatment of osteoporosis is lagging behind relative to other chronic disease states. NPs have a unique opportunity to help reduce this care gap by playing an integral role in the identification, risk stratification, and treatment of patients at risk for osteoporosis and fractures.

IMPLICATIONS FOR PRACTICE

This case highlights the important role an NP can have in screening a patient previously not diagnosed or managed for osteoporosis. Performing a focused history and physical exam of the patient to determine appropriate screening tests and fracture risk will help in guiding treatment decisions.

摘要

目的

采用基于病例的方法,我们回顾了在加拿大全科医疗环境中,与执业护士(NP)相关的、关于骨质疏松症和骨折风险患者的筛查、评估及治疗的关键临床问题。

数据来源

一个带有相关问题及答案的病例展示,以指导患者管理。

结论

骨质疏松症在老年男性和女性人群中均为常见病症。相对于其他慢性疾病状态,骨质疏松症的筛查、诊断及治疗较为滞后。执业护士有独特的机会通过在骨质疏松症和骨折风险患者的识别、风险分层及治疗中发挥不可或缺的作用,来帮助缩小这一医疗差距。

对实践的启示

本病例凸显了执业护士在筛查先前未被诊断或管理的骨质疏松症患者方面可发挥的重要作用。对患者进行重点病史询问和体格检查,以确定合适的筛查测试及骨折风险,将有助于指导治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec61/4140610/fa1013dd9986/jaan0026-0378-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec61/4140610/fa1013dd9986/jaan0026-0378-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec61/4140610/fa1013dd9986/jaan0026-0378-f1.jpg

相似文献

1
Screening, assessment, and treatment of osteoporosis for the nurse practitioner: key questions and answers for clinical practice--a Canadian perspective.执业护士对骨质疏松症的筛查、评估及治疗:临床实践关键问答——加拿大视角
J Am Assoc Nurse Pract. 2014 Jul;26(7):378-85. doi: 10.1002/2327-6924.12134. Epub 2014 Jun 9.
2
Closing the gap in osteoporosis management: the critical role of primary care in bone health.缩小骨质疏松症管理方面的差距:初级保健在骨骼健康中的关键作用。
Curr Med Res Opin. 2023 Mar;39(3):387-398. doi: 10.1080/03007995.2022.2141483. Epub 2023 Jan 24.
3
Barriers to secondary fracture prevention in primary care.初级保健中二级骨折预防的障碍。
Osteoporos Int. 2017 Oct;28(10):2913-2919. doi: 10.1007/s00198-017-4131-z. Epub 2017 Jun 29.
4
Osteoporotic Fracture Program management: who should be in charge? A comparative survey of knowledge in orthopaedic surgeons and internists.骨质疏松性骨折项目管理:应由谁负责?骨科医生和内科医生知识的比较调查。
Orthop Traumatol Surg Res. 2013 Oct;99(6):723-30. doi: 10.1016/j.otsr.2013.03.022. Epub 2013 Jul 10.
5
Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice.骨科诊所中骨质疏松症风险评估及执业护士干预项目的启动
Arch Osteoporos. 2016;11:10. doi: 10.1007/s11657-016-0262-7. Epub 2016 Feb 4.
6
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.《2010年加拿大骨质疏松症诊断与管理临床实践指南:摘要》
CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12.
7
Worldwide Fracture Prediction.全球骨折预测
J Clin Densitom. 2017 Jul-Sep;20(3):397-424. doi: 10.1016/j.jocd.2017.06.008. Epub 2017 Jul 19.
8
Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.护士病例管理者与多方面干预相结合以改善腕部骨折后骨质疏松症护理质量:随机对照试点研究。
Osteoporos Int. 2011 Jan;22(1):223-30. doi: 10.1007/s00198-010-1212-7. Epub 2010 Apr 1.
9
Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy's fracture clinic screening program.影响脆性骨折后骨质疏松症药物治疗的因素:安大略省骨质疏松症策略骨折诊所筛查计划的结果。
Osteoporos Int. 2014 Jan;25(1):289-96. doi: 10.1007/s00198-013-2430-6. Epub 2013 Jun 21.
10
[Management of osteoporosis after fragility fractures].[脆性骨折后骨质疏松症的管理]
Z Gerontol Geriatr. 2018 Jan;51(1):113-125. doi: 10.1007/s00391-017-1355-7. Epub 2018 Jan 5.

引用本文的文献

1
Efficacy of Moxibustion for Primary Osteoporosis: A Trial Sequential Meta-Analysis of Randomized Controlled Trials.艾灸治疗原发性骨质疏松症的疗效:随机对照试验的序贯Meta分析
Evid Based Complement Alternat Med. 2022 Sep 27;2022:1268876. doi: 10.1155/2022/1268876. eCollection 2022.
2
Implementing models of care for musculoskeletal conditions in health systems to support value-based care.在卫生系统中实施肌肉骨骼疾病的护理模式,以支持基于价值的护理。
Best Pract Res Clin Rheumatol. 2020 Oct;34(5):101548. doi: 10.1016/j.berh.2020.101548. Epub 2020 Jul 25.
3
Moxibustion treatment for primary osteoporosis: A systematic review of randomized controlled trials.

本文引用的文献

1
Early and late long-term effects of adjuvant chemotherapy.辅助化疗的早期和晚期长期影响。
Am Soc Clin Oncol Educ Book. 2013:9-14. doi: 10.14694/EdBook_AM.2013.33.9.
2
Direct medical resource utilization associated with osteoporosis-related nonvertebral fractures in postmenopausal women.绝经后妇女骨质疏松性非椎体骨折相关的直接医疗资源利用。
J Bone Miner Res. 2013 Feb;28(2):360-71. doi: 10.1002/jbmr.1756.
3
Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications.
艾灸治疗原发性骨质疏松症:随机对照试验的系统评价
PLoS One. 2017 Jun 7;12(6):e0178688. doi: 10.1371/journal.pone.0178688. eCollection 2017.
抗精神病药物治疗与低骨矿物质密度和骨质疏松症有关联吗?证据及临床意义综述。
Hum Psychopharmacol. 2012 Jan;27(1):15-23. doi: 10.1002/hup.1265. Epub 2012 Jan 9.
4
Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women.DAPS(地舒单抗依从性偏好满意度)研究的最终结果:一项为期 24 个月、随机、交叉比较绝经后妇女使用地舒单抗与阿仑膦酸钠的研究。
Osteoporos Int. 2012 Jan;23(1):317-26. doi: 10.1007/s00198-011-1780-1. Epub 2011 Sep 17.
5
Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.选择性 5-羟色胺再摄取抑制剂治疗与骨折风险:队列研究和病例对照研究的荟萃分析。
Osteoporos Int. 2012 Jan;23(1):365-75. doi: 10.1007/s00198-011-1778-8. Epub 2011 Sep 9.
6
Direct costs of fractures in Canada and trends 1996-2006: a population-based cost-of-illness analysis.加拿大骨折的直接成本及趋势 1996-2006:基于人群的疾病成本分析。
J Bone Miner Res. 2011 Oct;26(10):2419-29. doi: 10.1002/jbmr.457.
7
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada.加拿大安大略省双膦酸盐的处方、持续使用和累积暴露情况。
Osteoporos Int. 2012 Mar;23(3):1075-82. doi: 10.1007/s00198-011-1645-7. Epub 2011 May 21.
8
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.构建加拿大骨折风险评估 FRAX®模型及其对治疗的影响。
Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16.
9
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts.构建和验证加拿大男女简化骨折风险评估工具:来自 CaMos 和马尼托巴队列的结果。
Osteoporos Int. 2011 Jun;22(6):1873-83. doi: 10.1007/s00198-010-1445-5. Epub 2010 Oct 22.
10
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.《2010年加拿大骨质疏松症诊断与管理临床实践指南:摘要》
CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12.